Full Press Release Details
Ionis reports positive topline Phase 2 study results of its novel antisense treatment for hereditary angioedema.
IONS
Ionis reports positive topline Phase 2 study results of its novel antisense treatment for hereditary angioedema
Key Takeaway: Ionis reports positive topline Phase 2 study results of its novel antisense treatment for hereditary angioedema